InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Recruiting

Observational StudyInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Sponsor:

Dana-Farber Cancer Institute

Code:

NCT05463796

Conditions

Cancer Risk

Cancer Predisposition Syndrome

Hereditary Cancer Prediction

Childhood Cancer Survivors

Adult Cancer Survivors

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Accepted

Interventions

Samples

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Dana-Farber Cancer Institute on 2024-07-31.